GLYCEMIC IMPROVEMENT IN 1,311 PATIENTS WITH TYPE 1 DIABETES (T1D) USING THE OMNIPOD DASH® INSULIN MANAGEMENT SYSTEM OVER FIRST 90 DAYS OF USE

被引：0
|
作者：
Aleppo, G. [1 ]
Desalvo, D. [2 ]
Lauand, F. [3 ]
Huyett, L. [4 ]
Jantz, J. [5 ]
Chang, A. [5 ]
Vienneau, T. [6 ]
Ly, T. [7 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Texas Childrens Hosp, Pediat Diabet & Endocrinol, Houston, TX 77030 USA
[3] Insulet Int, Med Affairs, Paris, France
[4] Insulet Corp, Med Affairs, San Diego, CA USA
[5] Insulet Corp, Data Analyt, Acton, MA USA
[6] Insulet Corp, Med Affairs, Acton, MA USA
[7] Insulet Corp, Clin Affairs, Acton, MA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O081 / #34
引用
收藏
页码：A51 / A51
页数：1
相关论文
共 50 条
  • [1] Glycemic Improvement in 5,094 Pediatric Patients with Type 1 Diabetes (T1D) Using the Omnipod Insulin Management System over First 90 Days of Use
    Desalvo, Daniel
    Aleppo, Grazia
    Lauand, Felipe
    Huyett, Lauren M., Sr.
    Jantz, Jay
    Chang, Albert
    Vienneau, Todd
    Ly, Trang T.
    DIABETES, 2021, 70
  • [2] Glycemic improvement in 13,389 adults with type 1 diabetes (T1D) using the Omnipod® over the first 90 days of use
    Aleppo, Grazia
    DeSalvo, Daniel J.
    Mader, Julia K.
    Lauand, Felipe
    Huyett, Lauren M.
    Jantz, Jay
    Chang, Albert
    Vienneau, Todd
    Ly, Trang T.
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 232 - 232
  • [3] Glycaemic improvement in 3,436 people with type 1 diabetes using the Omnipod DASH® Insulin Management System over first 90 days of use
    Aleppo, G.
    DeSalvo, D. J.
    Lauand, F.
    Huyett, L. M.
    Chang, A.
    Vienneau, T.
    Ly, T. T.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 112 - 112
  • [4] Glycemic Improvement in 11,273 Adults with Type 1 Diabetes (11D) Using the Omnipod Insulin Management System over First 90 Days of Use
    Aleppo, Grazia
    Desalvo, Daniel
    Lauand, Felipe
    Huyett, Lauren M., Sr.
    Jantz, Jay
    Chang, Albert
    Vienneau, Todd
    Ly, Trang T.
    DIABETES, 2021, 70
  • [5] Patient-Reported Outcomes for 2,335 Adults with Type 2 Diabetes Using the Omnipod Insulin Management System Show Glycemic Improvement over First 90 Days of Use
    Carlson, Anders L.
    Huyett, Lauren M.
    Jantz, Jay
    Chang, Albert
    Vienneau, Todd
    Ly, Trang T.
    DIABETES, 2020, 69
  • [6] Evaluation of the Omnipod 5 Automated Insulin Delivery System in Very Young Children with Type 1 Diabetes (T1D)
    Sherr, Jennifer
    Bode, Bruce W.
    Forlenza, Gregory P.
    Laffel, Lori M.
    Brown, Sue A.
    Buckingham, Bruce A.
    Criego, Amy B.
    Desalvo, Daniel
    Macleish, Sarah A.
    Hansen, David W.
    Ly, Trang T.
    DIABETES, 2021, 70
  • [7] Impact of the Omnipod® Insulin Management System on Glycemic Control: A Survey of the T1D Exchange Glu Online Community
    Layne, Jennifer E.
    Ly, Trang T.
    DIABETES, 2017, 66 : A465 - A465
  • [8] Glycemic Outcomes for Adult Type 1 Diabetes (T1D) with and without DKA Treated with an Electronic Glycemic Management System
    Messler, Jordan
    Vellanki, Priyathama
    Bode, Bruce W.
    Booth, Robert
    Clarke, John
    DIABETES, 2021, 70
  • [9] Improvements in treatment satisfaction with Omnipod Dash insulin management system are durable over 24 weeks in adults with type 1 diabetes
    O'Neal, D. N.
    Kong, Y. W.
    Yuan, C. Y.
    Brown, K.
    Kiburg, K.
    Trawley, S.
    Partovi, A.
    Kerryn, R.
    Harrison, N.
    Fourlanos, S.
    Ekinci, E.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S385 - S385
  • [10] Impact of Insulin Regimen and Adherence on Glycemic Control in Youth with Type 1 Diabetes (T1D)
    Katz, Michelle L.
    Straussman, Sharon
    O'Donnell, Ellen
    Misra, Madhusmita
    Levitsky, Lynne L.
    DIABETES, 2011, 60 : A343 - A343
12345